Written by The Protein Sequencing Market is expanding as pharmaceutical companies, biotechnology firms, and research institutions increasingly rely on advanced protein analysis for drug discovery, biologics development, and precision medicine. The market was valued at USD 1.79 billion in 2025 and is projected to reach USD 2.98 billion by 2035, registering a CAGR of 4.72% during 2026–2035.
Technological advances in mass spectrometry, single-molecule sequencing, protein chip technology, and bioinformatics are transforming protein sequence analysis. Mass spectrometry remains an important platform for high-throughput workflows, while emerging single-molecule technologies are creating new possibilities for real-time protein identification and proteoform analysis.
Software and services held the largest product and service share at 41% in 2025, while reagents and consumables are projected to grow at a 6.9% CAGR. Biotherapeutics quality control and discovery accounted for 39% of the application market, and pharmaceutical companies represented the largest end-user segment with a 57% share.
North America led the market with approximately 46% of revenue in 2025, supported by strong pharmaceutical research and proteomics infrastructure. Asia-Pacific is expected to be the fastest-growing region at a 9.4% CAGR. Growing biologics pipelines, CRO outsourcing, AI-assisted sequencing, and multi-omics integration are expected to create further opportunities through 2035.
Explore additional reports to understand evolving market landscapes:
GCC Percutaneous Coronary Intervention Market Outlook
UK Hematology Diagnostics Market Analysis
GCC Remote Patient Monitoring Market Distribution